55566-1010Level 3
Fyremadel (ganirelix acetate)
**Product type:** Human Prescription Drug
**Active ingredient:** GANIRELIX ACETATE
**Strength:** 250 ug/.5mL
**Dosage form:** Injection, Solution
**Route:** Subcutaneous
**Labeler:** Ferring Pharmaceuticals Inc.
**Marketing category:** ANDA (ANDA204246)
**Pharmacologic class:** Decreased GnRH Secretion [PE], Gonadotropin Releasing Hormone Receptor Antagonist [EPC], Gonadotropin Releasing Hormone Receptor Antagonists [MoA]
GET
/api/v1/systems/ndc_fda/nodes/55566-1010Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.